Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseAnalysis of Human RSV Immunity at the Molecular Level: Learning from the Past and PresentVirus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infectionProtective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo.Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion proteinIntranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategiesRespiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responsesChinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccineCytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccineReplication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.Immune responses and disease enhancement during respiratory syncytial virus infectionRespiratory syncytial virus vaccinesGene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.Immunity to RSV in Early-Life.Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseGinseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.The use of a neonatal mouse model to study respiratory syncytial virus infections.Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse.The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsetsAbsence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccineProgress in understanding and controlling respiratory syncytial virus: still crazy after all these yearsC5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expressionAlum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune CellsRespiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.
P2860
Q26775152-0D608EB2-B46A-47A3-9C5C-EE405A5D6BE0Q28080556-7EBA34A4-1844-4A0D-94E6-ECA2CC63D888Q30452584-B346C2C2-32C4-4180-9732-FA48105736FCQ30485791-E1DC6B7E-C2B4-44F8-8CDD-3B3488228781Q32099239-FA194491-CA9F-4AD2-B72D-CD2F82D315CFQ33558475-F7641C50-5785-41FB-AB8E-1899153C11C4Q33603913-4769B2BA-A9F6-48AD-B245-B4653FF61AE5Q33613442-F26B953B-A198-4CB3-AEE5-85C3E95B08E3Q33738521-B4028626-DDDC-4A59-957D-F1526C48C516Q33754172-50099192-EA6C-47A6-82BC-BC8C786808BFQ33780476-F9F5B2DA-502A-4406-93ED-4C6709957C51Q33781642-C701DD5E-A567-442C-BB4B-1C3680EA68D2Q33785332-0202FDEF-6E47-4558-800D-FE82D08EC3D7Q33849224-521B1BDB-2F91-4348-AD0E-0170BD353307Q33870528-D67242EF-532D-479D-AFF2-CE885DC9B651Q33937152-C05C48D0-9EBD-4D10-AAE1-CE151D9A3D15Q33975330-5110DAF4-A20B-4D82-BA23-FA5FFEED3674Q34120191-471137C4-8AAB-4C85-A763-FD9FC6D94E29Q34157386-5F67041A-6F31-46AB-BE80-FF61E6025AE6Q34264615-65A276F1-5CFF-4941-92C4-969237A6127BQ34330690-463D7563-3FD8-42E1-ADB7-A087CDEB3E3EQ34440116-42C3994B-C502-4F5D-9756-DCD6251A5E91Q34465367-EAAB1C87-393F-42B7-9548-B16FA6F850DDQ34504791-9D1025FE-EE51-4905-895F-DE0B058B3893Q34549253-61709E98-9862-4BBC-89B3-6AE933ED538AQ34569141-22571FC7-DB84-42C8-B052-CF6F2769CD45Q34651258-9467CAAE-425E-40E8-A1DE-645315EDBEC0Q34791209-CDFA27F9-3AC0-4ACF-A29A-74E155F1EA3BQ34948645-F1229180-A63C-49C2-86CC-E4450AB4EA16Q34991432-316CC9AF-AED7-4D9D-BC05-AB548FA0D267Q35063967-EDAAE799-E1D6-4020-A31D-0A53893CF306Q35077892-9140B520-A575-4C23-82A3-8FC0DA0F5B23Q35174945-78728318-6DD6-4852-B34B-D703151B5836Q35196230-636229E3-CDA7-4299-9E12-0AA176638E27Q35566601-DA5F90AF-24B3-43AD-A605-397037110543Q35634924-D0197093-4C68-4082-B129-DEB8A62E0FDBQ35808047-39E5C4F8-BA77-47D3-9914-3C6C5711B332Q35859950-CCA37A57-5D90-4C37-BB2A-ABAAA5AA28C2Q35872191-AB1B49B0-631E-49C0-8E99-5AD88852D943Q35892441-0D789E95-BEE2-4E36-90B1-955149EF6E8A
P2860
Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@ast
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@en
type
label
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@ast
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@en
prefLabel
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@ast
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@en
P2093
P2860
P1433
P1476
Pulmonary histopathology induc ...... d by depletion of CD4+ T cells
@en
P2093
Firestone CY
Kulkarni AB
Morse HC 3rd
Sotnikov AV
P2860
P304
P407
P577
1992-12-01T00:00:00Z